Del Monte Corporation Chairman and CEO Mohammad Abu-Ghazaleh joined Bloomberg Open Interest to explain why the iconic food brand reunited after nearly four decades and discusses easing supply chain pressures. He also reveals some surprising pharmaceutical research using pineapple-derived compounds (Source: Bloomberg)
Trending
- GLP-1 implant from Vivani Medical aims to help patients stay on treatment
- Goldman Sachs picks its favorite Chinese AI models
- Prediction markets spark insider trading fears. How firms are responding
- Top analysts are confident about these 3 stocks for the long haul
- Oil prices rise, stock futures dip after latest flare-up of strikes between U.S. and Iran
- Cattle Extending Losses to Friday
- Charges against man accused of running crypto fraud will be dropped
- Vietnam tracks towards credit growth target
Monday, July 13
